Skip to main content

Table 3 Comparison between NTS bacteraemia patients with or without severe immunosuppression

From: Non-typhoidal Salmonella bacteraemia: Epidemiology, clinical characteristics and its' association with severe immunosuppression

Variable Overall
n(%)/median(± IQR)
(n = 55)
Severe immunosuppression
n(%)/median (± IQR)
p OR 95%C1
   Yes (n = 36) No(n = 19)    
Age > 50 a 18(32.7) 6(16.7) 12(63.2) 0.001 0.12 0.03–0.42
Male b 37(67.3) 24(66.7) 13(68.4) 0.89 0.92 0.28–3.034
EF1 b 17(30.9) 10(27.8) 7(36.8) 0.49 0.66 0.20–2.15
Mycotic aneurysm a 3(5.5) 0(0) 3(15.8) 0.037 undefined
Gastroenteritis b 16(29.1) 7(19.4) 9(47.4) 0.03 0.27 0.079–0.91
Primary bacteraemia b 23(41.8) 19(52.8) 4 (21.1) 0.023 4.19 1.16–15.11
Atherosclerosis a 12(21.8) 4(11.1) 8(42.1) 0.015 0.17 0.043–0.69
Mortalitya 12(21.8) 11(30.6) 1(5.3) 0.041 7.92 0.94–66.97
Salmonella Enteritidis b 40(72.7) 29(80.6) 11(57.9) 0.073 3.013 0.88–10.30
Group D Salmonellaa 43(78.2) 31(86.1) 12(63.2) 0.084 3.62 0.96–13.64
Hospital acquisition a 10(18.2) 9(25.0) 1 (5.3) 0.14 6 0.70–51.53
Septic shock a 5(9.1) 4(11.1) 1(5.3) 0.65 2.25 0.23–21.69
Fever a 42(76.4) 27(75) 15(78.9) 1.00 1.25 0.33–4.76
Paediatric a 13(23.6) 10(27.8) 3(15.8) 0.51 0.49 0.12–2.04
Opportunistic infections a 11(20) 11(30.6) 0(0) 0.01 Undefined
Leukopenia b 15(27.3) 15(41.6) 0(0) 0.001 undefined
Blood culture positivity < 24 hours b 35(63.6) 24(66.7) 11(57.9) 0.52 1.45 0.46–4.57
Age (years) c 39(43.0) 36.5(31.25) 64.0(41.0) 0.005 NA  
Duration of hospitalization (days) c 9(13.0) 8.0(16.0) 10.0(12.0) 0.18 NA  
Leukocytes/mm3c 7.7(7.0) 5.5(7.18) 8.3(5.7) 0.016 NA  
Lymphocytes/mm3 c 1.1(1.4) 0.9(1.0) 1.9(2.2) 0.026 NA  
Duration of symptoms (days) c 5(4.0) 5.0(4.0) 5.0(4.0) 0.98 NA  
  1. a Fisher's exact test; b Chi-squared test; c Non-parametric Mann-Whitney test.
  2. a and b expressed as number (%); c expressed as median (± IQR)
  3. NA = not applicable